Table 5.
Cd concentrations in biological samples of participants
| Metalsa | Group | N | AM ± SDb | G.M (95 % C.I)c | Min–Maxd | p valuee |
|---|---|---|---|---|---|---|
| B-Cd (μg/L) | Case | 9 | 6.05 ± 3.13 | 5.33 (3.63, 7.45) | 2.29–11.66 | 0.000 |
| Control | 28 | 1.99 ± 1.12 | 1.63 (1.23, 2.08) | 0.20–4.04 | ||
| U-Cd (μg/L) | Case | 9 | 7.26 ± 4.32 | 5.31 (2.57, 9.80) | 0.67–11.93 | 0.003 |
| Control | 28 | 2.95 ± 3.51 | 1.02 (0.45, 2.04) | NDf–15.46 | ||
| U-Cd (μg/g-cr) | Case | 9 | 7.43 ± 4.59 | 6.19 (3.76, 9.13) | 1.44–17.67 | 0.000 |
| Control | 26 | 2.53 ± 2.50 | 1.16 (0.61, 2.05) | 0.05–7.73 |
a B-Cd blood Cd concentration, U-Cd urine Cd Concentration
bArithmetic mean ± standard deviation
cGeometric mean (95 % Confidence Interval)
dMinimum–maximum
eIndependent sample t test
fNot detected